|
|
||||||||
From the Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago College of Medicine, Chicago, Illinois.
PURPOSE. To examine ultrastructurally the composition of extracellular matrix (ECM) materials, the distribution of myocilin, and the colocalization of myocilin with ECM components in the juxtacanalicular tissue (JCT) of normal human eyes.
METHODS. Postembedding immunoelectron microscopic studies were performed with antibodies specific for major ECM components, including fibronectin, laminin, vitronectin, tenascin, elastin, fibrillin-1, microfibril-associated glycoprotein (MAGP)-1, decorin, versican, and five types of collagen (I, III, IV, V, and VI). Hyaluronic acid was localized with the use of biotinylated hyaluronic acidbinding protein. Colloidal gold labeling was also performed using an anti-human myocilin polyclonal antibody. Colocalization of myocilin with ECM components was examined by double labeling, using different-sized gold particles. The possible interaction between myocilin and ECM molecules was evaluated by in vitro binding assays.
RESULTS. Amorphous basement membrane-like materials in the JCT were confirmed to be made up chiefly of collagen type IV, laminin, and fibronectin. Elastin was localized to the central core of sheath-derived plaques. Fibronectin, fibrillin-1, MAGP-1, decorin, and type VI collagen were all localized to clusters of the banded material in the sheath surrounding the core, where several types of collagen, glycoproteins, and proteoglycans were also detected. Myocilin was found to associate mainly with the sheath material, overlapping extensively in distribution with fibronectin, fibrillin-1, and MAGP-1 and moderately with decorin and type VI collagen. Its localization was distinct from that of elastin. Interactions of myocilin with molecules such as fibronectin and fibrillin-1 were confirmed biochemically.
CONCLUSIONS. This study illustrated ultrastructurally the composition of ECM materials in the JCT of normal human eyes. The key finding was the association of myocilin with microfibrillar architecture in sheath-derived plaques where pathologic changes have been documented to occur in eyes of patients with primary open-angle glaucoma.
This article has been cited by other articles:
![]() |
P. Russell, J. Z. Gasiorowski, P. F. Nealy, and C. J. Murphy Response of Human Trabecular Meshwork Cells to Topographic Cues on the Nanoscale Level Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 629 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sanchez-Sanchez, F. Martinez-Redondo, J. D. Aroca-Aguilar, M. Coca-Prados, and J. Escribano Characterization of the Intracellular Proteolytic Cleavage of Myocilin and Identification of Calpain II as a Myocilin-processing Protease J. Biol. Chem., September 21, 2007; 282(38): 27810 - 27824. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Sodium 4-Phenylbutyrate Acts as a Chemical Chaperone on Misfolded Myocilin to Rescue Cells from Endoplasmic Reticulum Stress and Apoptosis Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1683 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wiggs Genetic Etiologies of Glaucoma Arch Ophthalmol, January 1, 2007; 125(1): 30 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Aggregated Myocilin Induces Russell Bodies and Causes Apoptosis: Implications for the Pathogenesis of Myocilin-Caused Primary Open-Angle Glaucoma Am. J. Pathol., January 1, 2007; 170(1): 100 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Gould, M. Reedy, L. A. Wilson, R. S. Smith, R. L. Johnson, and S. W. M. John Mutant Myocilin Nonsecretion In Vivo Is Not Sufficient To Cause Glaucoma Mol. Cell. Biol., November 15, 2006; 26(22): 8427 - 8436. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakai, B.-C. Park, X. Shen, and B. Y. J. T. Yue Transduction of TAT Fusion Proteins into the Human and Bovine Trabecular Meshwork. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4427 - 4434. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gonzalez Jr, J. A. Faralli, J. M. Peters, J. R. Newman, and D. M. Peters Effect of Heparin II Domain of Fibronectin on Actin Cytoskeleton and Adherens Junctions in Human Trabecular Meshwork Cells. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2924 - 2931. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Fautsch, C. K. Bahler, A. M. Vrabel, K. G. Howell, N. Loewen, W. L. Teo, E. M. Poeschla, and D. H. Johnson Perfusion of His-Tagged Eukaryotic Myocilin Increases Outflow Resistance in Human Anterior Segments in the Presence of Aqueous Humor Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 213 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Bhattacharya, E. J. Rockwood, S. D. Smith, V. L. Bonilha, J. S. Crabb, R. W. Kuchtey, N. G. Robertson, N. S. Peachey, C. C. Morton, and J. W. Crabb Proteomics Reveal Cochlin Deposits Associated with Glaucomatous Trabecular Meshwork J. Biol. Chem., February 18, 2005; 280(7): 6080 - 6084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zillig, A. Wurm, F. J. Grehn, P. Russell, and E. R. Tamm Overexpression and Properties of Wild-Type and Tyr437His Mutated Myocilin in the Eyes of Transgenic Mice Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gobeil, M.-A. Rodrigue, S. Moisan, T. D. Nguyen, J. R. Polansky, J. Morissette, and V. Raymond Intracellular Sequestration of Hetero-oligomers Formed by Wild-Type and Glaucoma-Causing Myocilin Mutants Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3560 - 3567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ueda and B. Y. J. T. Yue Distribution of Myocilin and Extracellular Matrix Components in the Corneoscleral Meshwork of Human Eyes Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4772 - 4779. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Tomarev, G. Wistow, V. Raymond, S. Dubois, and I. Malyukova Gene Expression Profile of the Human Trabecular Meshwork: NEIBank Sequence Tag Analysis Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2588 - 2596. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |